Recent interest in multiple sclerosis research warrants literature analysis to evaluate the current state of the discipline and new research domains. This bibliometric review summarised the research trends and analysed research areas in multiple sclerosis over the last decade. The documents containing the term ‘multiple sclerosis’ in the article title were retrieved from the Scopus database. We used Harzing’s Publish or Perish and VOSviewer for citation analysis and data visualisation, respectively. We found a total of 18,003 articles published in journals in the English language between 2012 and 2021. The emerging keywords identified utilising the enhanced strategic diagram were ‘covid-19’, ‘teriflunomide’, ‘clinical trial’, ‘microglia’, ‘b cells’, ‘myelin’, ‘brain’, ‘white matter’, ‘functional connectivity’, ‘pain’, ‘employment’, ‘health-related quality of life’, ‘meta-analysis’ and ‘comorbidity’. This study demonstrates the tremendous growth of multiple sclerosis literature worldwide, which is expected to grow more than double during the next decade especially in the identified emerging topics.
HauserSLCreeBAC. Treatment of multiple sclerosis: A review. Am J Med2020; 133(12): 1380–1390.e2.
3.
WaltonCKingRRechtmanL, et al. Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition. Mult Scler2020; 26(14): 1816–1821.
4.
HarirchianMHFatehiFSarrafP, et al. Worldwide prevalence of familial multiple sclerosis: A systematic review and meta-analysis. Mult Scler Relat Disord2017; 20: 43–47.
5.
OlssonTBarcellosLFAlfredssonL. Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis. Nat Rev Neurol2017; 13(1): 25–36.
6.
EllegaardOWallinJA. The bibliometric analysis of scholarly production: How great is the impact?Scientometrics2015; 105(3): 1809–1831.
7.
ZakariaRAhmiAAhmadAH, et al. Worldwide melatonin research: A bibliometric analysis of the published literature between 2015 and 2019. Chronobiol Int2021; 38(1): 27–37.
8.
ZakariaRAhmiAAhmadAH, et al. Visualising and mapping a decade of literature on honey research: A bibliometric analysis from 2011 to 2020. J Apic Res2021; 60(3): 359–368.
9.
DonthuNKumarSMukherjeeD, et al. How to conduct a bibliometric analysis: An overview and guidelines. J Bus Res2021; 133: 285–296.
10.
Aleixandre-BenaventRAlonso-ArroyoAGonzález De DiosJ, et al. Bibliometric profile of the global scientific research on multiple sclerosis (2003-2012). Mult Scler2015; 21(2): 235–245.
11.
HoYSShekoftehM. Performance of highly cited multiple sclerosis publications in the Science Citation Index expanded: A scientometric analysis. Mult Scler Relat Disord2021; 54: 103112.
12.
Van EckNJWaltmanL. VOSviewer manual: Manual for VOSviewer version 1.6.16. Leiden: Universiteit Leiden, 2020.
13.
FengJMuXWangW, et al. A topic analysis method based on a three-dimensional strategic diagram. J Inf Sci2021; 47: 770–782.
14.
CoboMJLópez-HerreraAGHerrera-ViedmaE, et al. An approach for detecting, quantifying, and visualizing the evolution of a research field: A practical application to the Fuzzy Sets Theory field. J Informetri2011; 5(1): 146–166.
15.
HansenDShneidermanBSmithM, et al. Social network analysis: Measuring, mapping and modelling collections of connections. In: HansenDLShneidermanBSmithMA, et al. (eds) Analyzing social media networks with NodeXL. 2nd ed.Burlington, MA: Morgan Kaufmann, 2020, pp. 31–51.
16.
GolbexkJ. Introduction to social media investigation: A hand-on approach. 1st ed. Waltham, MA: Syngress Publishing, 2015.
17.
HuCPHuJMDengSL, et al. A co-word analysis of library and information science in China. Scientometrics2013; 97(2): 369–382.
18.
RaynaudMGoutaudierVLouisK, et al. Impact of the COVID-19 pandemic on publication dynamics and non-COVID-19 research production. BMC Med Res Methodol2021; 21: 255.
19.
ZupicIČaterT. Bibliometric methods in management and organization. Organ Res Methods2015; 18(3): 429–472.
20.
BaiYLiHLiuY. Visualizing research trends and research theme evolution in E-learning field: 1999-2018. Scientometrics2021; 126: 1389–1414.
21.
CreeBACGoldmanMDCorboyJR, et al. Efficacy and safety of 2 fingolimod doses vs glatiramer acetate for the treatment of patients with relapsing-remitting multiple sclerosis: A randomized clinical trial. JAMA Neurol2020; 78(1): 1–13.
22.
JalkhGAbi NahedRMacaronG, et al. Safety of newer disease modifying therapies in multiple sclerosis. Vaccines2020; 9(1): 12.
23.
YangCCRoLSTsaiNW, et al. Real-world evidence on the safety and effectiveness of fingolimod in patients with multiple sclerosis from Taiwan. J Formos Med Assoc2021; 120(1 Pt 2): 542–550.
24.
ZiemssenTAkgünKBrückW. Molecular biomarkers in multiple sclerosis. J Neuroinflammation2019; 16: 272.
PaulAComabellaMGandhiR. Biomarkers in multiple sclerosis. Cold Spring Harb Perspect Med2019; 9(3): a029058.
27.
NourbakhshBRevirajanNMorrisB, et al. Safety and efficacy of amantadine, modafinil, and methylphenidate for fatigue in multiple sclerosis: A randomised, placebo-controlled, crossover, double-blind trial. Lancet Neurol2021; 20(1): 38–48.
28.
RazazianNKazeminiaMMoayediH, et al. The impact of physical exercise on the fatigue symptoms in patients with multiple sclerosis: A systematic review and meta-analysis. BMC Neurol2020; 20: 93.
29.
GascoyneCKarahaliosADemaneufT, et al. Effect of exercise interventions on anxiety in people with multiple sclerosis: A systematic review and meta-analysis. Int J MS Care2020; 22(3): 103–109.
30.
BenedictRHBAmatoMPDeLucaJ, et al. Cognitive impairment in multiple sclerosis: Clinical management, MRI, and therapeutic avenues. Lancet Neurol2020; 19(10): 860–871.
31.
SumowskiJFBenedictREnzingerC, et al. Cognition in multiple sclerosis: State of the field and priorities for the future. Neurology2018; 90(6): 278–288.
32.
PetraccaMPontilloGMocciaM, et al. Neuroimaging correlates of cognitive dysfunction in adults with multiple sclerosis. Brain Sci2021; 11(3): 346.
33.
HatipogluHCanbaz KabaySGungor HatipogluM, et al. Expanded disability status scale-based disability and dental-periodontal conditions in patients with multiple sclerosis. Med Princ Pract2016; 25(1): 49–55.
34.
BrancoMAlvesIMartinsDaSilvaA, et al. The epidemiology of multiple sclerosis in the entre Douro e Vouga region of northern Portugal: A multisource population-based study. BMC Neurol2020; 20: 195.
35.
ManteroVAbateLSalmaggiA, et al. Multiple sclerosis and COVID-19: How could therapeutic scenarios change during the pandemic?J Med Virol2021; 93(4): 1847–1849.
36.
ManteroVBaronciniDBalgeraR, et al. Mild COVID-19 infection in a group of teriflunomide-treated patients with multiple sclerosis. J Neurol2021; 268(6): 2029–2030.
37.
CencioniMTMattoscioMMagliozziR, et al. B cells in multiple sclerosis – From targeted depletion to immune reconstitution therapies. Nat Rev Neurol2021; 17: 399–414.
38.
MonroeKMDi PaoloG. Microglia clean up toxic lipids in multiple sclerosis. Nat Neurosci2021; 24(4): 451–452.
39.
LehmannAIRodgersSKammCP, et al. Factors associated with employment and expected work retention among persons with multiple sclerosis: Findings of a cross sectional citizen science study. J Neurol2020; 267(10): 3069–3082.
40.
VisserLALouapreCUyl-De GrootCA, et al. Health-related quality of life of multiple sclerosis patients: A European multi-country study. Arch Public Health2021; 79: 39.
41.
LiuYDuanYDongH, et al. Disrupted module efficiency of structural and functional brain connectomes in clinically isolated syndrome and multiple sclerosis. Front Hum Neurosci2018; 12: 138.
42.
MeijerKASteenwijkMDDouwL, et al. Long-range connections are more severely damaged and relevant for cognition in multiple sclerosis. Brain J Neurol2020; 143: 150–160.
43.
ShuNDuanYHuangJ, et al. Progressive brain rich-club network disruption from clinically isolated syndrome towards multiple sclerosis. Neuroimage Clin2018; 19: 232–239.
44.
JandricDDoshiAScottR, et al. A systematic review of resting-state functional MRI connectivity changes and cognitive impairment in multiple sclerosis. Brain Connect. Epub ahead of print6October2021. DOI: 10.1089/brain.2021.0104.
45.
MagyariMSorensenPS. Comorbidity in multiple sclerosis. Front Neurol2020; 11: 851.
46.
ForouhariATaheriGSalariM, et al. Multiple sclerosis epidemiology in Asia and Oceania; A systematic review and meta-analysis. Mult Scler Relat Disord2021; 54: 103119.
47.
YanKBalijepalliCDesaiK, et al. Epidemiology of pediatric multiple sclerosis: A systematic literature review and meta-analysis. Mult Scler Relat Disord2020; 44: 102260.
48.
KouchakiENamdariMKhajealiN, et al. Prevalence of suicidal ideation in multiple sclerosis patients: Meta-analysis of international studies. Soc Work Public Health2020; 35(8): 655–663.
